Mr. Zhang Liangchuan l Medicine and Dentistry
| Best Researcher Award

Mr. Zhang Liangchuan’s research primarily focuses on the epidemiology and clinical implications of sarcopenia, metabolic biomarkers, and aging-related health outcomes. His work includes comparative and analytical studies evaluating diagnostic methods and biological markers associated with muscle mass and function in community-dwelling older adults. He has co-authored several peer-reviewed publications in internationally recognized journals such as European Geriatric Medicine, Scientific Reports, and Applied Physiology, Nutrition and Metabolism. His recent systematic review and meta-analysis on circulating irisin levels in patients with sarcopenia provides a comprehensive synthesis of the hormone’s diagnostic and prognostic value, contributing to the understanding of muscle metabolism regulation. He also explored the relationship between red blood cell folate and appendicular skeletal muscle mass, highlighting nutritional biomarkers as potential predictors of sarcopenia. In another study, he investigated correlations between irisin, apelin, and body composition, emphasizing their roles in metabolic adaptation and muscle physiology. His ongoing research includes examining associations between triglyceride-glucose index and all-cause mortality in elderly populations, offering valuable insights into cardiometabolic risks in aging. Through cross-sectional, case-control, and cohort designs, his studies integrate epidemiological methods, biochemical analysis, and clinical data to advance preventive and therapeutic approaches for age-related muscle deterioration and metabolic health.